MedPath

A study on the application method for prevention/reduction of the local irritation with the benzoyl peroxide preparations for acne vulgaris patients.

Phase 4
Conditions
acne vulgaris
Registration Number
JPRN-UMIN000031922
Lead Sponsor
PO Health Institute Research of Skin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
121
Inclusion Criteria

Not provided

Exclusion Criteria

1) Treated for acne vulgaris within one month before the study 2) Contraindicated for the investigational drugs 3) Continuous use of nonsteroidal anti-inflammatory drugs (such as ibuprofen) 4) Pregnant or possibly pregnant women, lactating women, and women who wanted to become pregnant during the study period. 5) Judged as ineligible by the physician directing the study 6) Participation in another clinical study or post-marketing surveillance of other drugs for acne vulgaris within six months before the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath